A Double-Blind, Placebo-Controlled, Safety Tolerability and Pharmacokinetics Study in Parkinson¿s Disease Participants Treated with Carbidopa/Levodopa and NE3107 Phase 2a
Administered By
Awarded By
Contributors
- Cooney, Jeffrey W Principal Investigator
Start/End
- February 22, 2022 - December 31, 2023